5 Key Takeaways
-
1
Interventional glaucoma therapy improves patient compliance and reduces financial burdens compared to traditional treatments.
-
2
Minimally invasive glaucoma surgery (MIGS) offers effective long-term solutions with less tissue manipulation than conventional surgery.
-
3
The LiGHT trial demonstrated the efficacy and safety of MIGS over traditional glaucoma drops, influencing treatment standards.
-
4
Despite evidence supporting MIGS, only 20-50% of ophthalmologists utilize selective laser trabeculoplasty as first-line therapy.
-
5
Transitioning to an interventional approach is expected to enhance glaucoma management while alleviating burdens on patients and doctors.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.